WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

List of DDDs for 3 years revision

8he DDDs, which will be reviewed at the March 2018 meeting (3 year revision) are listed below.  See also Guidelines: Part III; D Principles for reviewing and changing DDD and Part V; D Requests for changes to DDDs. The deadline for applications for alterations and comments is 1 February 2018.  

 

ATC codeATC level name (INN/generic name)DDDUnitAdm.route
J01XB01colistin3MUInhal. powder
N06BA11dexmethylphenidate15mgO
N05AX12aripiprazole13.3mgP depot
L04AC11siltuximab37mgP
L04AA33vedolizumab5.4mgP
L04AA29tofacitinib10mgO
L02BX01abarelix3.6mgP
J05AP07daclatasvir60mgO
G02AD06misoprostol0.2mg1)
C10AX12lomitapide40mgO
C09CA09azilsartan medoxomil40mgO
C02KX05riociguat4.5mgO
A16AX08teduglutide5mgP
A10BJ05dulaglutide0.16mgP
A10BJ04albiglutide5.7mgP
A10BK03empagliflozin17.5mgO
A10BH04alogliptin25mgO
N05AH01loxapine9.1mg 2)Inhal. powder
R03CC13clenbuterol40mcgO
R03AC19olodaterol5mcgInhal. solution
L03AB13peginterferon beta-1a8.9mcgP
R03BB07umeclidinium bromide55mcg 3)Inhal. powder
V03AX03cobicistat0.15gO
V03AE05sucroferric oxyhydroxide1.5gO
P01BE03artesunate0.28gP
N06BA13armodafinil0.15gO
J05AP09dasabuvir0.5gO
J05AP05simeprevir0.15gO
A16AX10eliglustat0.168gO
A10BK02canagliflozin0.2gO
1) vaginal insert, refers to the content of one vaginal insert
2) delivered dose
3) Refers to umeclidinium, delivered dose

Last updated: 2018-01-23